Sangamo Biosciences, Inc. (SGMO) Posts Q2 EPS Loss of $0.20, Releases FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +25.0%
Financial Fact:
Basic and diluted net loss per share: -0.27
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.65 million.
Sangamo Biosciences, Inc. sees FY2011 revenue of $10-$12 million, versus the consensus of $11.03 million.
Sangamo Biosciences, Inc. sees FY2011 revenue of $10-$12 million, versus the consensus of $11.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
- Steel Dynamics issues Q2 2026 earnings guidance of $3.51-$3.55 per share
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
